High titer recombinant AAV vector production in adherent and suspension cells Grant US-11834683-B2 United States of America 05 Dec 2023
High titer recombinant AAV vector production in adherent and suspension cells Grant US-11078464-B2 United States of America 03 Aug 2021
EBOLA VACCINE COMPOSITIONS AND METHODS OF USING SAME Application WO-2020044267-A1 World Intellectual Property Organisation (WIPO) 05 Mar 2020
Recombinant virus production using mammalian cells in suspension Grant US-9783826-B2 United States of America 10 Oct 2017
Cell line for production of adeno-associated virus Grant US-9441206-B2 United States of America 13 Sep 2016
Pharmacologically induced transgene ablation system Grant US-9315825-B2 United States of America 19 Apr 2016
CELL LINE FOR PRODUCTION OF ADENO-ASSOCIATED VIRUS Application EP-2771455-A4 European Patent Office 15 Apr 2015
HIGH TITER RECOMBINANT AAV VECTOR PRODUCTION IN ADHERENT AND SUSPENSION CELLS Application WO-2015031686-A1 World Intellectual Property Organisation (WIPO) 05 Mar 2015
CELL LINE FOR PRODUCTION OF ADENO-ASSOCIATED VIRUS Application EP-2771455-A1 European Patent Office 03 Sep 2014
INDUCIBLE ADENO -ASSOCIATED VIRUS VECTOR MEDIATED TRANSGENE ABLATION SYSTEM Application WO-2013049493-A1 World Intellectual Property Organisation (WIPO) 04 Apr 2013
RECOMBINANT VIRUS PRODUCTION USING MAMMALIAN CELLS IN SUSPENSION Application EP-2242840-A4 European Patent Office 19 Dec 2012
PHARMACOLOGICALLY INDUCED TRANSGENE ABLATION SYSTEM Application WO-2011126808-A2 World Intellectual Property Organisation (WIPO) 13 Oct 2011
RECOMBINANT VIRUS PRODUCTION USING MAMMALIAN CELLS IN SUSPENSION Application EP-2242840-A1 European Patent Office 27 Oct 2010